Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_assertion type Assertion NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_head.
- NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_assertion description "[Known oncogenic ERBB2 alterations were identified in tumors derived from 27 tissues, and ERBB2 amplification in breast, gastric, and gastroesophageal cancers accounted for only 30% of these alterations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_provenance.
- NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_assertion evidence source_evidence_literature NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_provenance.
- NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_assertion SIO_000772 25480824 NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_provenance.
- NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_assertion wasDerivedFrom befree-2016 NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_provenance.
- NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_assertion wasGeneratedBy ECO_0000203 NP1245356.RAIEr9eo3-WAzM6ATaBmKqGkkFplgBdnXOnSotVOB49sI130_provenance.